Use of GLP-1 Drugs to Treat Overweight or Obesity Increased 587 Percent from 2019 to 2024, According to New FAIR Health Study News provided by FAIR Health May 27, 2025, 08:11 ET GLP-1 Prescriptions Increased 364 Percent for All Adults, and 588 Percent for Younger Adults Bariatric Surgeries Declined 42 Percent NEW YORK, May 27, 2025 /PRNewswire/ -- Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR Health data
As expected with caloric restriction and weight loss, there were significant improvements in several metabolic parameters between Day 1 and Day 20 including glycemic control, plasma lipids, and leptin that were similar in both groups (Table 2)
Without sufficient levels of both L-Carnitine and CoQ10 you will be less likely to burn fat efficiently, and will likely have much less energy
Beyond appetite suppression, GLP-1 medications improve how your body regulates blood sugar and may increase metabolic rate